ASKP3 Expert Faculty
The ASKP3 Expert Faculty members are developing a roadmap for the future of ketamine and emerging treatments that are rooted in research, education, and standards of best practice. Expert Faculty members also serve as an extension of the ASKP3 Board of Directors, providing input and guidance on practice issues in the ketamine field, as needed.
Annually, the ASKP3 Board of Directors reviews the list of Faculty and makes adjustments to ensure that the faculty represents our intradisciplinary community.
We are actively seeking ASKP3 members to join our Expert Faculty through an annual application process at the start of the year. Applications for consideration to serve as Expert Faculty are accepted in the Fall. Selection and notification of Expert Faculty is posted by December 1. Expert Faculty meet, in-person, the day prior to the ASKP3 Annual Conference.
Siddharth Arora, MD
Amna M. Aslam, MBA, MSc
Arsalan Azam, MD
Michael Banov, MD
Glen Brooks, MD
Shannon Darling, PMHNP-BC
John Dougherty, DO
Lara Edinger, DO
David Feifel, MD, PhD
Tiago Gil, MD
Lucinda Grande, MD, FASAM
Ruchir Gupta, MD
Irfan Handoo, MD
Sam Ko, MD
Jack Korbutov, PharmD, RPH, FACA, FACVP
Michael Kritzer-Cheren, MD, PhD
Kim Le, MD
Carlene MacMillan, MD
Michael Mantz, MD
David Mathai, MD
Alison McInnes
Rupert McShane, MD, FRCPsych
Charles Miller, MSN, CRNA
Bruce Nadro, DO
Brittany O’Brien, PhD
Chris Pateros, MA, RN
Tatiana Santini, MA, RP, RCC, SEP
Sam Schulze, PMHNP-BC
Scott Shannon, MD
Lowan Stewart, MD
Gita Vaid, MD
Tammy Vaught, CRNA, APRN, PMHNP-BC
Sara Whaley
Laura Wiginton, LCSW
Stefany Wolfsohn, MD
